Insulet Corporation Financial Statements
Insulet Corporation Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
| Investor Relations | Company Web Site |
Insulet Corporation Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 13.4 | 3.7 | 0.1 |
| Gross Profit ($ mil.) | (12.4) | (12.0) | (1.5) |
| Operating Income ($ mil.) | (53.8) | (34.6) | (21.5) |
| Total Net Income ($ mil.) | (53.5) | (36.0) | (21.6) |
| Diluted EPS (Net Income) | (3.21) | (99.72) | (70.95) |
Insulet Corporation Stock Quote & Chart
| 10/10/08 15:00:03 EST •
NASDAQ •
8.02
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Insulet Corporation Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 23.24 | 2.16 | 1.55 |
| Price/Earnings Ratio | -- | 22.12 | 15.75 |
| Price/Book Ratio | 5.69 | 2.26 | 1.49 |
| Price/Cash Flow Ratio | -- | 16.10 | 9.68 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Insulet Corporation Financial Ratios
Insulet Corporation Competitive Intelligence
| Animas | Medtronic MiniMed | Smiths Medical ASD | |
|---|---|---|---|
| Annual Sales ($ mil.) | 26.5 | 168.3 | 84.6 |
| Employees | 348 | 2,000 | 1,125 |
| Market Cap ($ mil.) | -- | -- | -- |
Competitive Landscape





